CyclicCAE outperforms GenKIC by rapidly generating energetically stable heterochiral macrocycle backbones, advancing macrocycle drug design.
- Open access
- 2 cites
Moving in bioRxiv, Nature Communications, Nature Chemical Biology and Molecular Cell.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
CyclicCAE outperforms GenKIC by rapidly generating energetically stable heterochiral macrocycle backbones, advancing macrocycle drug design.
Tryptoline acrylamide stereoprobes can disrupt the GRPEL1-HSPA9 complex by targeting nonorthosteric sites, impairing mitochondrial protein import and mitophagy.
Proteome-guided drug discovery identified linker modifications that reduce hepatotoxicity and improve safety of androgen receptor-targeting degraders for prostate cancer.
AI-driven virtual screening expands DEL hits, identifying 14 compounds with IC50 values ≤ 100 μM, enhancing chemical diversity and drug-likeness.
Generative AI-designed thiolation domains enable up to threefold increased yields in reprogrammed non-ribosomal peptide synthetases.
Combinatorial deep mutational scanning reveals epistatic superbinders that bind 3- to 5-fold tighter than existing PIN1 WW-domain binders.
Journals this month
Topics moving, week to 23 Oct 2026